The research & development by business enterprise, pharmaceutical industry in constant ppp $ in Norway is now 39.85 million, marking a 0.95 million (2.4%) increase compared to 2020.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Norway
No matching regions
Similar regions to Norway
Business R&D pharmaceutical in constant PPP $
More indicators for Norway
Government R&D in security as % of government support
2.91%
+0.22%
(2021)
Higher-education-finacing R&D financed by general university in local currency
184,346.70M
+6,664.70M
(2021)
R&D financed by rest of the world in local currency
65,896.14M
+4,998.14M
(2021)
Government R&D financed by rest of the world in local currency
6,078.91M
+222.91M
(2021)
Business R&D financed by rest of the world in local currency
48,835.97M
+3,672.97M
(2021)
Non-profit R&D growth rate
-100%
-120.34%
(2022)
Norway Business R&D pharmaceutical in constant PPP $ between 1987 and 2021
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2021 | 39.85M | +0.95M |
| 2020 | 38.90M | -0.24M |
| 2019 | 39.14M | -0.92M |
| 2018 | 40.06M | +0.98M |
| 2017 | 39.08M | +3.93M |
| 2016 | 35.15M | +1.91M |
| 2015 | 33.24M | -1.83M |
| 2014 | 35.07M | -5.37M |
| 2013 | 40.44M | -1.99M |
| 2012 | 42.43M | -37.58M |
| 2011 | 80.02M | +23.70M |
| 2010 | 56.31M | +2.24M |
| 2009 | 54.08M | -6.42M |
| 2008 | 60.50M | -2.89M |
| 2007 | 63.39M | +1.86M |
| 2006 | 61.54M | -3.03M |
| 2005 | 64.57M | -8.53M |
| 2004 | 73.10M | +11.63M |
| 2003 | 61.47M | +4.46M |
| 2002 | 57.02M | -8.08M |
| 2001 | 65.10M | -15.77M |
| 2000 | 80.87M | -7.23M |
| 1999 | 88.10M | +14.98M |
| 1998 | 73.12M | +16.79M |
| 1997 | 56.33M | -2.28M |
| 1996 | 58.61M | -12.56M |
| 1995 | 71.17M | -11.24M |
| 1993 | 82.42M | +0.79M |
| 1992 | 81.62M | +3.30M |
| 1991 | 78.32M | +3.82M |
| 1990 | 74.49M | +6.92M |
| 1989 | 67.57M | +11.24M |
| 1988 | 56.33M | +14.42M |
| 1987 | 41.91M |